[Recombinant thymosin alpha1].
Esipov. R S RS; Gurevich. A I AI; Stepanenko. V N VN; Chupova. L A LA; Chuvikovskiĭ. D V DV; Miroshnikov. A I AI
Key Findings
- Artificial gene for thymosin‑alpha‑1 was created by chemoenzymatic synthesis
- Hybrid protein with a yeast intein was expressed in E. coli
- Non‑enzymatic cleavage conditions were identified to release pure thymosin‑alpha‑1
Practical Outcomes
- The study is mainly about peptide production, not about how to use thymosin‑alpha‑1 for longevity or performance. Unless you have advanced biotech skills, it offers no actionable protocol for dosing or safety.
Summary
The paper explains a lab technique for making thymosin‑alpha‑1 in bacteria using genetic engineering, but it doesn’t test the peptide’s health effects or give dosing advice, so it isn’t directly useful for everyday biohacking or self‑experimentation.
Abstract
An artificial gene encoding thymosin alpha1 was obtained by the chemoenzymatic synthesis and cloned into Escherichia coli. An expressing recombinant plasmid containing the hybrid protein gene, which encodes amino acid sequences of thymosin alpha1 and the Saccharomyces cerevisiae intein Sce VMA, was constructed. The expression of the hybrid protein from the resulting hybrid gene in E. coli, the properties of the resulting hybrid protein, and the conditions for its nonenzymatic cleavage to thymosin alpha1 were studied. The English version of the paper: Russian Journal of Bioorganic Chemistry, 2004, vol. 30, no. 5; see also http: // www.maik.ru.
Study Information
pubmed
2004
10.1023/b:rubi.0000043785.41076.56